MTOR and colorectal cancer: In another study, lncRNA CKMT2-AS1 depressed the growth of colorectal cancer cells by targeting the AKT/mTOR pathway [41], which contradicts our data that lncRNA CKMT2-AS1 could be a poor indicator for pRCC rather than a protective factor (Figure 3G–I).